Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Cholesterol Management Gaps Among Patients With Established Coronary Artery Disease Hospitalized for Acute Coronary Events. Local targets link to admitted publications; unresolved targets remain external evidence.
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines
10.1016/j.jacc.2018.11.003 · 2019 · External reference
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines
10.1016/j.jacc.2025.11.016 · 2026 · External reference
Myocardial infarction and physical function: the REasons for geographic and racial differences in stroke prospective cohort study
10.1136/bmjph-2023-000107 · 2023 · External reference
Acute and 1-Year hospitalization costs for acute myocardial infarction treated with percutaneous coronary intervention: results from the TRANSLATE-ACS registry
10.1161/jaha.118.011322 · 2019 · External reference
Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65,396 hospitalizations from 344 hospitals participating in Get With The Guidelines (GWTG)
10.1016/j.ahj.2010.08.041 · 2010 · External reference
Trends in high-intensity statin therapy after myocardial infarction among U.S. adults, 2011-2019
10.1016/j.jacc.2022.02.049 · 2022 · External reference
Low-density lipoprotein cholesterol levels in adults with coronary artery disease in the US, January 2015 to march 2020
10.1001/jama.2023.8646 · 2023 · External reference
Improved treatment of hospitalized coronary artery disease patients with the get with the guidelines program
10.1097/hpc.0b013e31812da7ed · 2007 · External reference
Association of region and hospital and patient characteristics with use of high-intensity statins after myocardial infarction among medicare beneficiaries
10.1001/jamacardio.2019.2481 · 2019 · External reference
Sex differences in high-intensity statin use following myocardial infarction in the United States
10.1016/j.jacc.2018.02.032 · 2018 · External reference
Adherence to statin therapy among US adults between 2007 and 2014
10.1161/jaha.118.010376 · 2019 · External reference
Disparities in guideline-recommended statin use for prevention of atherosclerotic cardiovascular disease by race, ethnicity, and gender: a nationally representative cross-sectional analysis of adults in the United States
10.7326/m23-0720 · 2023 · External reference
Prevalence of statin use for primary prevention of atherosclerotic cardiovascular disease by race, ethnicity, and 10-Year disease risk in the US: National health and nutrition examination surveys, 2013 to march 2020
10.1001/jamacardio.2023.0228 · 2023 · External reference
KDIGO clinical practice guideline for lipid management in chronic kidney disease
2013 · External reference
2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Solution Set Oversight Committee
10.1016/j.jacc.2022.07.006 · 2022 · External reference
2015 ACC/AHA focused update of secondary prevention lipid performance measures: a report of the American College of Cardiology/American Heart Association task force on performance measures
10.1016/j.jacc.2015.02.003 · 2016 · External reference
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: a joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology
10.1016/j.ajpc.2023.100472 · 2023 · External reference
Methods for estimating prevalence ratios in cross-sectional studies
10.1590/s0034-89102008000600003 · 2008 · External reference
Race/Ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction
10.1016/j.jacl.2021.08.001 · 2021 · External reference
Empowering research with the American Heart Association get with the guidelines registries through integration of a database and research tools
10.1161/circoutcomes.124.010967 · 2024 · External reference
Secondary prevention after myocardial infarction in the United States
10.1016/j.jacc.2026.03.157 · 2026 · External reference
Trends in U.S. Ambulatory Cardiovascular Care 2013 to 2017: JACC review topic of the week
10.1016/j.jacc.2019.11.011 · 2020 · External reference
Achievement of LDL-C <55 mg/dL among US adults: findings from the cvMOBIUS2 registry
10.1016/j.ahj.2024.06.012 · 2025 · External reference
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials
10.1016/s0140-6736(14)61368-4 · 2015 · External reference
Use of lipid-lowering therapies over 2 years in GOULD, a registry of patients with atherosclerotic cardiovascular disease in the US
10.1001/jamacardio.2021.1810 · 2021 · External reference
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
10.1056/nejmoa040583 · 2004 · External reference
Recurrent atherosclerotic cardiovascular disease events potentially prevented with guideline-recommended cholesterol-lowering therapy following myocardial infarction
10.1007/s10557-023-07452-1 · 2024 · External reference
Lipid management in contemporary community practice: results from the Provider Assessment of Lipid Management (PALM) registry
10.1016/j.ahj.2017.08.005 · 2017 · External reference
Lipid-lowering therapy use and intensification among United States veterans following myocardial infarction or coronary revascularization between 2015 and 2019
10.1161/circoutcomes.121.008861 · 2022 · External reference
Interventions to improve adherence to lipid-lowering drugs: a systematic review and meta-analysis
10.1016/j.eclinm.2025.103270 · 2025 · External reference
Low-density lipoprotein cholesterol testing following myocardial infarction hospitalization among medicare beneficiaries
10.1016/j.jacadv.2023.100753 · 2024 · External reference
American heart Association national integrated ASCVD initiative: an implementation initiative to improve lipid management among patients with ASCVD
10.1161/circoutcomes.124.011627 · 2025 · External reference
Willingness to be reinitiated on a statin (from the REasons for geographic and racial differences in stroke study)
10.1016/j.amjcard.2018.05.016 · 2018 · External reference
Black-white differences in incident fatal, nonfatal, and total coronary heart disease
10.1161/circulationaha.116.025848 · 2017 · External reference
Illustrating bias due to conditioning on a collider
10.1093/ije/dyp334 · 2010 · External reference
Patient co-payment and adherence to statins: a review and case studies
10.1007/s10557-013-6497-2 · 2014 · External reference
Full coverage for preventive medications after myocardial infarction
10.1056/nejmsa1107913 · 2011 · External reference
American Association of Clinical Endocrinology Clinical Practice guideline on pharmacologic management of adults with dyslipidemia
10.1016/j.eprac.2024.09.016 · 2025 · External reference
Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care
10.3399/bjgp18x696173 · 2018 · External reference
Cholesterol lowering in older adults: should we wait for further evidence?
10.1007/s11883-024-01224-4 · 2024 · External reference
